Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

49
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
49
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Gene Therapy00:59

Gene Therapy

27.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.8K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.6K
Overview
80.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

17.1K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and biodistribution of XC001 (encoberminogene rezmadenovec) gene therapy in rats: a potential therapy for cardiovascular diseases.

Gene therapy·2023
Same author

Partial rescue of the Tbx1 mutant heart phenotype by Fgf8: genetic evidence of impaired tissue response to Fgf8.

Journal of molecular and cellular cardiology·2010
Same author

Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice.

The Journal of clinical investigation·2009
Same author

Non-Antibody Protein Therapeutics Development & Production--IBC Conference. Successful strategies for bringing protein therapeutics to market.

IDrugs : the investigational drugs journal·2009
Same author

Early thyroid development requires a Tbx1-Fgf8 pathway.

Developmental biology·2009
Same author

Gain of function of Tbx1 affects pharyngeal and heart development in the mouse.

Genesis (New York, N.Y. : 2000)·2009

Related Experiment Video

Updated: Feb 26, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K

Gene Therapy.

Barb Thorne1, Ryan Takeya2, Francesca Vitelli3

  • 1Thorne Bio-Consulting LLC, Sammamish, WA, USA.

Advances in Biochemical Engineering/Biotechnology
|March 15, 2017
PubMed
Summary
This summary is machine-generated.

Gene therapy utilizes viral vectors to deliver therapeutic genes, advancing medicine. This review details manufacturing processes and presents a large-scale AAV production case study to guide future scalable therapies.

Keywords:
AAVGene therapyLarge-scale productionViral vector

More Related Videos

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

11.9K
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

15.7K

Related Experiment Videos

Last Updated: Feb 26, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

2.2K
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

11.9K
CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy
08:22

CRISPR/Cas9-mediated Targeted Integration In Vivo Using a Homology-mediated End Joining-based Strategy

Published on: March 12, 2018

15.7K

Area of Science:

  • Biotechnology
  • Molecular Medicine
  • Genetic Engineering

Background:

  • Gene therapy is a rapidly advancing medical field using gene transfer to treat diseases.
  • Modified viral vectors are common delivery systems due to their high transduction efficiency.
  • Recent clinical successes necessitate scalable, robust, and cost-effective manufacturing processes.

Purpose of the Study:

  • To review current manufacturing technologies for viral vector production in gene therapy.
  • To highlight common upstream and downstream processes and unique challenges.
  • To present a case study of large-scale AAV-based gene therapy manufacturing.

Main Methods:

  • Overview of established viral vector production platforms.
  • Analysis of upstream and downstream processing steps.
  • Detailed case study of a 2,000 L cGMP AAV production run.

Main Results:

  • Viral vector production shares common platforms but has unique challenges compared to other biologics.
  • A 2,000 L scale cGMP production of an AAV-based gene therapy product was successfully conducted.
  • Key experiences and lessons learned from the large-scale production run were documented.

Conclusions:

  • Scalable, robust, and regulatory-compliant manufacturing is crucial for the commercialization of gene therapies.
  • The presented case study offers valuable insights for future industrial-scale viral vector production.
  • Successful large-scale manufacturing is essential to meet the growing demand for gene therapy products.